Robotic suit kicks off World Cup; Singapore, South Korea finance med tech development center; FDA revised guidance on magnetic resonance diagnostic devices;

@FierceMedDev: Chrono Therapeutics snares $32M in Series A money for wearable smoking cessation device. More | Follow @FierceMedDev

@StacyALawrence: Mobile medical app brings laboratory testing to the home. Story | Follow @StacyALawrence

@MichaelGFierce: UCSB study: New silver nanoparticles dissolve if they don't hit their mark. FierceDrugDelivery story | Follow @MichaelGFierce

@EmilyWFierce: C.R. Bard wins unanimous FDA panel vote for drug-eluting balloon catheter. Article | Follow @EmilyWFierce

> A mind-controlled robotic suit developed by a Brazilian scientist at Duke helped 29-year-old paraplegic Juliano Pinto kick off the World Cup yesterday. Story

> A med tech development center opened under the joint cooperation of Singapore and South Korea, with companies and local partners able to tap a $5 million fund. More

> The FDA has revised its guidance on magnetic resonance diagnostic devices for better risk compliance. Documents

Biotech News

@FierceBiotech: What's next in diabetes drugs? The pulse of R&D at ADA14. More | Follow @FierceBiotech

@JohnCFierce: Vertex down about 8% now as this Porges note rattles investors. Story | Follow @JohnCFierce

@DamianFierce: Check out FierceBiotech's full 2014 ADA coverage here. | Follow @DamianFierce

> Once-monthly MS drug from Biogen Idec, AbbVie clears Phase III hurdle. More

> Boehringer, Lilly creep up on Sanofi with Lantus biosimilar. Story

> Sanofi's Lantus heir beats its forebear in controlling diabetes. Article

Pharma News

@FiercePharma: Top-read on FP this weekend: Roche and Cipla are ordered to mediate in a new twist on Indian IP fights.Story | Follow @FiercePharma

@TracyStaton: Trending now @FiercePharma: Novo Nordisk lays out plans to recruit 6,000 workers in R&D, production. Story | Follow @TracyStaton

@EricPFierce: In Allergan and Valeant takeover fight, silence is Goldman. More | Follow @EricPFierce

@CarlyHFierce: ICYMI--NYT: Goldman Sachs caught in the middle of Valeant, Allergan takeover fight. Article | Follow @CarlyHFierce

@JustinHFierce: PetVivo ($PETV) updates study on Kush medical device to treat animal osteoarthritis with Gel-Del, CEO Lai: "Mobility." Release | Follow @JustinHFierce

> Could Pfizer nab AstraZeneca with pipeline-based payouts? Maybe, but cash is easier. Story

> Sources: Bayer, J&J's Xarelto faces first U.S. lawsuits. More

CRO News

> InVentiv, Oncobiologics kick off their biosimilar alliance, target Humira. More

> Karyopharm taps CRO Veristat for cancer R&D. Story

> Quintiles signs an expansive deal to chart effects of physical therapy. Article

> Korean pharma booster recruits Novotech to boost local R&D. Report

> After a year of dealmaking, PRA settles in with a new identity. News

Biotech IT News

> EMA backtracks on clinical trial data download ban. News

> Illumina working to turn smartphones into 'molecular stethoscopes.' More

> Google inks deal with Autism Speaks, commits to housing 10,000 whole genomes. Article

> Pfizer strikes tech-enabled drug discovery deal with X-Chem. Story

> AstraZeneca sponsors diabetes patient registry. More

Suggested Articles

J.D. Power aims to set the benchmarks in telehealth satisfaction with a new study due this November.

Atomwise plans to screen up to 10 billion virtual compounds for therapies against childhood cancer in collaboration with chemical supplier Enamine.

The Chan Zuckerberg Initiative set aside $68 million for over three dozen projects in an effort to map out every type of cell in the body.